• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Moderna Inc (NQ: MRNA )

    54.63 +0.27 (+0.50%)
    Official Closing Price Updated: 4:15 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Moderna Inc

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    2 Dividend Stocks to Buy for a Lifetime of Passive Income
    These are the kinds of stocks that can allow investors to sleep easy at night. 
    Via The Motley Fool
    These 10 Stocks Were S&P 500's Top Performers In Biden's First Year: Could The Trend Continue If Harris Wins 2024 Election?
    A look at the top 10 performing S&P 500 stocks in 2021 could point to trends to watch if Kamala Harris wins the 2024 election. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Moderna to Present at Upcoming Conferences in November 2024
    Via ACCESSWIRE
    Behind the Scenes of Moderna's Latest Options Trends
    Via Benzinga
    Why Is Moderna Stock Trading Higher On Monday?
    Merck and Moderna initiate Phase 3 trial of mRNA-4157 (V940) with Keytruda as adjuvant for NSCLC patients, marking progress in individualized cancer therapies. 
    Via Benzinga
    Moderna Unusual Options Activity For October 22
    Via Benzinga
    A Closer Look at Moderna's Options Market Dynamics
    Via Benzinga
    If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,900 Today
    Via Benzinga
    Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)
    From Merck & Co., Inc.
    Via Business Wire
    Large-Cap Stocks In Trouble - Sunday, Oct. 27
    Here’s this week’s top 10 worst performing Large-Caps in the last twelve months. 
    Via Talk Markets
    Moderna Named a Top Employer by Science for Tenth Consecutive Year
    Via ACCESSWIRE
    How Bad Is This News for Novavax?
    Novavax stock fell 20% in one trading session on the news. 
    Via The Motley Fool
    Unveiling 18 Analyst Insights On Moderna
    Via Benzinga
    (MRNA) - Analyzing Moderna's Short Interest
    Via Benzinga
    Large-Cap Stocks In Trouble - Saturday, Oct. 19
    Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns. 
    Via Talk Markets
    Benzinga Bulls And Bears: Apple, Tesla, Netflix, Oklo — And Dogecoin, Meme Coins Outpace Corporate Giants
    Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories. 
    Via Benzinga
    Goldman Sachs Highlights 20 Top Short-Squeeze Opportunities For Q3 Earnings Season
    Goldman Sachs identified 20 stocks with high short interest that could be primed for a short squeeze. Hint: A pet retailer tops the chart. 
    Via Benzinga
    Netflix, TSMC, American Express, Moderna, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
    S. markets ended Thursday with mixed performance: the Dow Jones Industrial Average climbed 0.4% to 43,239.05. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology
    Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle technology without permission in the development of its COVID-19 vaccines. 
    Via Benzinga
    Topics Lawsuit
    Exposures COVID-19 Financial Legal
    Moderna to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024
    Via ACCESSWIRE
    Cathie Wood Continues To Sell Shares Of Jack Dorsey's Bitcoin-Focused Company Block — Ark Also Dumps Moderna, Robinhood Stock
    On Wednesday, Cathie Wood’s Ark Invest made significant trades involving Block Inc (NYSE:SQ) and Moderna Inc (NASDAQ:MRNA). The SQ Trade 
    Via Benzinga
    Cathie Wood's Ark Offloads $1.28M In Jack Dorsey's Block Shares Despite Bitcoin Rally
    On Tuesday, Cathie Wood-led Ark Invest made significant trades, most notably selling off shares of Block Inc. (NYSE:SQ). The SQ Trade 
    Via Benzinga
    GSK Sues Moderna Alleging mRNA Vaccine Patent Infringement
    GlaxoSmithKline has filed a lawsuit against Moderna, claiming its mRNA vaccines infringe on GSK's patents. GSK seeks royalties for Moderna's alleged unlicensed use of its groundbreaking vaccine... 
    Via Benzinga
    Topics Intellectual Property Lawsuit
    Exposures Financial Intellectual Property Legal
    The Bull's Biggest Hits And Misses
    The bull market turned two years old over the weekend. Here are some of the S&P 500's biggest winners and losers over the last two years. 
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    Large-Cap Stocks In Trouble - Sunday, Oct. 13
    Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns. 
    Via Talk Markets
    2 Biotech Stocks That Are Screaming Buys This Month
    They won't remain southbound forever. 
    Via The Motley Fool
    Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table
    On Thursday Oct 10, 2024 Cathie Wood-Led Ark Invest sold over $9 million worth of Moderna stock. 
    Via Benzinga
    Personalized Treatment And Immunotherapy Are Pharma's Newest Weapons Against Cancer
    On Sunday, The Guardian issued an article that spoke of a UK study that could transform how cancer is treated. The large-scale clinical project assessed how personalized cancer therapies could... 
    Via Benzinga
    MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.